Biohaven
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · Connecticut, United States · 201-500 Employees
View Company Info for Free
Overview
Headquarters
234 Church St, New Haven, Connecticut, 0...Phone Number
(203) 404-0410Website
www.biohaven.comRevenue
$541.5 MillionStock Symbol
BHVNIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Biohaven
Founded in 2022, Biohaven is a pharmaceutical company developing and commercializing life changing new therapies for people with debilitating diseases.Explore more
Biohaven Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Biohaven your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Biohaven had a recent Job posting/layoffs
Check out if Biohaven is spiking on competitors!
Funding: Get notified immidiatlly once Biohaven has new funding data
Check if Biohaven has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Biohaven recently announced quarterly report
Biohaven, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Biohaven
Product Launch: Get notified when Biohaven launches new products
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Reach out to Masked Content who joined Biohaven as Masked Content
Find 2 more new buyers
Compare Similar Companies to Biohaven
Compare insights from companies similar to Biohaven, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Biohaven is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Biohaven is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Biohaven.
Biohaven Tech Stack
A closer look at the technologies used by Biohaven
See more technologies
Most Recent Scoops
Person-Based
Earnings, Pharmaceuticals, Clinical Operations, Finance
Person-Based
Medical Research, Pharmaceuticals, Clinical Operations
Person-Based
Person-Based
Intellectual Property, Lawsuits, Legal Affairs
Person-Based
Medical Research, Pharmaceuticals, Clinical Operations
Biohaven News & Media
Biohaven and SK Biopharmaceuticals Enter into Strategic Global Licensing Agreement for Novel Kv7 Ion Channel Platform and Opakalim, Lead Candidate for Epilepsy
SK Biopharmaceuticals to provide upfront and milestone payments related to the Kv7 platform up to $795 million, along with tiered royalties to Biohaven ranging from the mid-teens to low twenties on U.S. net sales of opakalim. Opakalim, the lead candidate from Biohaven's Kv7 platform, is a...Federal Court Enters Judgment Confirming RA Capital and Avilar Therapeutics Willfully and Maliciously Misappropriated Trade Secret Developed at Yale, Formalizing $4 Million Award to Biohaven and Yale University
NEW HAVEN, Conn., Aug. 25, 2026 /PRNewswire/ -- Biohaven Ltd. and/or its wholly owned subsidiaries ("Biohaven") (NYSE: BHVN) and Yale University ("Yale") today announced that the U.S. District Court for the District of Delaware has entered judgment in their favor in the trade secret...Biohaven Appoints Technology Investor John Yetimoglu to Board of Directors
Infinitum founder and Groq board director brings frontier AI and technology-investing expertise to Biohaven as the company advances AI-enabled approaches to drug development NEW HAVEN, Conn., Aug. 6, 2026 /PRNewswire/ -- Biohaven Ltd. (NYSE: BHVN), a global biopharmaceutical company,...Federal Jury Finds Avilar Therapeutics and RA Capital Willfully and Maliciously Misappropriated Trade Secret Developed at Yale, Awards Biohaven and Yale University $4 Million
NEW HAVEN, Conn., July 27, 2026 /PRNewswire/ -- Biohaven Ltd. and/or its wholly owned subsidiaries ("Biohaven") (NYSE: BHVN) and Yale University ("Yale") today announced that a federal jury in the U.S. District Court for the District of Delaware returned a verdict in their favor in the...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Biohaven
Sign Up For FreeTo access detailed company insights
Founded in 2022, Biohaven is a pharmaceutical company developing and commercializing life changing new therapies for people with debilitating diseases.... Read More
